GENE ONLINE|News &
Opinion
Blog

2022-08-31| InterviewsSpecial

Scaling up Korea’s Biotech Presence in The Global Value Chain, an Interview with Seung Kyou Lee, Vice President of KoreaBIO

by Reed Slater
Share To
South Korea’s remarkable industrial and economic growth in the last century has pushed it into one of the top-ranking positions in the world. Electronics manufacturing and steel production spearheaded the country’s rise to prosperity, and in recent years, its emerging biotechnology industry is proving to be another huge step in the country’s evolution. Companies like Samsung, Celltrion, and SK Bioscience have made Korea one of the leading countries in Asia in the biotech industry. 
At BIOPLUS-INTERPHEX (BIX) Korea 2022 in Seoul, an annual conference bringing together biotech industry professionals from around the world, Vice President of KoreaBIO, Seung Kyou Lee, sat down and highlighted Korean biotech’s most promising and exciting trends. Lee covered everything from connecting in person again, the current and hopeful future state of the Korean biotech industry, and what it might take for Korea to take a more prominent position on the global stage.123

It's free! Log in now to read

LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top